Janet Mj Hammond, Chief Development Officer at Atea Pharmaceuticals, Inc. (AVIR), sold 28,058 shares at $3.84 ($108K) on 2024-02-01, disclosed to the SEC on 2024-02-02.
Open-market sale of $108k AVIR by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.84 | 14,029 | $54K | 50.0% |
| 2 | $3.84 | 14,029 | $54K | 50.0% |
| Total | $3.84 avg | 28,058 | $108K | 100% |